Patrick Lucy
Net worth: 58 427 $ as of 2026-05-30
Net worth: 58 427 $ as of 2026-05-30
Patrick K.
Lucy was the founder of Pelican, Inc., founded in 2009, serving as Chief Business Officer & Senior Vice President from 2017 to 2020.
Mr. Lucy is currently Chief Executive Officer & Director at Wheeler Bio, Inc. since 2024 and Chairman at Dyadic International, Inc. since 2024.
Former positions include President & Chief Executive Officer at Roslin Cell Therapies Ltd., Director-Business Development at Collaborative BioAlliance Inc & Collaborative Smithfield Corp from 1999 to 2002, Director-Business Development at Dowpharma from 2002 to 2009, Principal at The Dow Chemical Co., Principal at Repligen Corp.
from 1991 to 1998, Manager-Validation & Capital Project at Lonza Biologics Plc from 1998 to 1999, and President & Chief Operating Officer at Lykan Bioscience LLC in 2021.
Education includes undergraduate studies at Villanova University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-23 | 72,311 ( 0.2% ) | 58 427 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| DYADIC INTERNATIONAL, INC. | Chairman | 2024-03-27 |
Wheeler Bio, Inc.
Wheeler Bio, Inc. Pharmaceuticals: OtherHealth Technology Operates as a contract development and manufacturing organization that discovers & develops process for biopharmaceutical companies | Chief Executive Officer | 2024-10-08 |
| Companies | Position | End |
|---|---|---|
| PFENEX INC. | Chief Executive Officer | 2017-08-02 |
Dowpharma
Dowpharma Chemicals: SpecialtyProcess Industries Manufactures and distributes chemical, pharmaceutical & biopharmaceutical products | Corporate Officer/Principal | 2008-12-31 |
Collaborative BioAlliance Inc & Collaborative Smithfield Corp
Collaborative BioAlliance Inc & Collaborative Smithfield Corp Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical drugs | Corporate Officer/Principal | 2001-12-31 |
Lonza Biologics Plc
Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies | Corporate Officer/Principal | 1998-12-31 |
| REPLIGEN CORPORATION | Corporate Officer/Principal | 1997-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
Repligen Corp.
Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Dyadic International, Inc.
Dyadic International, Inc. Medical/Nursing ServicesHealth Services Manufactures genes and other biological products | Health Services |
Lonza Biologics Plc
Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies | Commercial Services |
Collaborative BioAlliance Inc & Collaborative Smithfield Corp
Collaborative BioAlliance Inc & Collaborative Smithfield Corp Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical drugs | Health Technology |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dowpharma
Dowpharma Chemicals: SpecialtyProcess Industries Manufactures and distributes chemical, pharmaceutical & biopharmaceutical products | Process Industries |
Pelican Inc
Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Lykan Bioscience LLC
Lykan Bioscience LLC Pharmaceuticals: MajorHealth Technology Develops cell and gene therapies | Health Technology |
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapeutics | Health Technology |
Wheeler Bio, Inc.
Wheeler Bio, Inc. Pharmaceuticals: OtherHealth Technology Operates as a contract development and manufacturing organization that discovers & develops process for biopharmaceutical companies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions